Ten years of Orthoclone OKT3 (muromonab-CD3): a review (Q28241114)

Progress in Transplantation: the journal for procurement and clinical transplant professionals

Europe PubMed Central

title

Ten years of Orthoclone OKT3 (muromonab-CD3): a review (English)

0 references

author name string

S L Smith

series ordinal

1

0 references

language of work or name

English

0 references

publication date

September 1996

0 references

published in

0 references

volume

6

0 references

page(s)

109-19; quiz 120-1

0 references

issue

3

0 references

cites work

Continuous cultures of fused cells secreting antibody of predefined specificity

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.1.6.3.8145L3U185493182

Monoclonal Antibodies Defining Distinctive Human T Cell Surface Antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.1.6.3.8145L3U185493182

The use of OKT3 in cadaveric renal transplantation for rejection that is unresponsive to conventional anti-rejection therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.1.6.3.8145L3U185493182

A prospective study on the use of monoclonal anti-T3-cell antibody (OKT3) to treat steroid-resistant liver transplant rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.1.6.3.8145L3U185493182

Monoclonal antibodies in organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.1.6.3.8145L3U185493182

Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.1.6.3.8145L3U185493182

Muromonab CD3. A review of its pharmacology and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.1.6.3.8145L3U185493182

Anaphylactic shock after retreatment with OKT3 monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.1.6.3.8145L3U185493182

Induction of thromboses within renal grafts by high-dose prophylactic OKT3

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.1.6.3.8145L3U185493182

A retrospective analysis of the effect of indomethacin on adverse reactions to orthoclone OKT3 in the therapy of acute renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.1.6.3.8145L3U185493182

A Randomized Prospective Trial of Acyclovir and Immune Globulin Prophylaxis in Liver Transplant Recipients Receiving OKT3 Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.1.6.3.8145L3U185493182

Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.1.6.3.8145L3U185493182

Immunosuppression and Malignant Neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.1.6.3.8145L3U185493182

Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.1.6.3.8145L3U185493182